2013
DOI: 10.1016/j.fct.2013.05.040
|View full text |Cite
|
Sign up to set email alerts
|

Screening of Lactobacillus strains for their ability to bind Benzo(a)pyrene and the mechanism of the process

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
46
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 63 publications
(47 citation statements)
references
References 17 publications
1
46
0
Order By: Relevance
“…() and Zhao et al . () found that LABs and probiotics can bind BaP and show antimutagenic activities against BaP. It has been reported by Zhu et al .…”
Section: Discussionmentioning
confidence: 70%
See 2 more Smart Citations
“…() and Zhao et al . () found that LABs and probiotics can bind BaP and show antimutagenic activities against BaP. It has been reported by Zhu et al .…”
Section: Discussionmentioning
confidence: 70%
“…Furthermore, probiotics can adsorb different toxic compounds in their cell surface through physical interactions (Zhao et al . ; Serrano‐Niño et al . ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many interesting mutants with high activity were identified from the metagenome of bacteria in chemical plant sludge. The ability of the CueO protein and its mutants to degrade benzo[α]pyrene, a mutagenic and highly carcinogenic environmental polycyclic aromatic hydrocarbon (PAH), was evaluated (Zhao et al 2013). The results indicate that the cloned cueO mutants could catalyze transformation of PAHs, similar to the function of fungal laccase from Trametes versicolor (Zeng et al 2011(Zeng et al , 2016Hullo et al 2001;Roberts et al 2002).…”
Section: Open Accessmentioning
confidence: 99%
“…Furthermore, other mechanisms could explain the high interest in the use of probiotics as a potential preventive food against CRC, such as competitive exclusion of pathogenic intestinal flora (Rafter, 2003), alteration of intestinal flora enzyme activity (Goldin & Gorbach, 1984), reduction of carcinogenic secondary bile acids (De Boever et al, 2000), binding of carcinogens (Fotiadis, Stoidis, Spyropoulos, & Zografos, 2008), production of anti-tumorigenic or antimutagenic compounds (Zhao et al, 2013). Sivieri et al (2008) demonstrated that the oral administration of Enterococcus faecium CRL 183 resulted in a significant reduction of DMH-induced ACF formation in male Wistar rats.…”
Section: Introductionmentioning
confidence: 99%